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Resumen
Objetivo. Determinar la prevalencia y el tratamiento de la
hipertensión arterial en ancianos en México. Material y
métodos. De enero a julio de 1998, se llevó a cabo un
estudio transversal en ancianos derechohabientes del
Instituto Mexicano del Seguro Social. La población de estudio
consistió de 4 777 ancianos, seleccionados de una cohorte
representativa de 5 433 sujetos residentes en el Distrito
Federal. Enfermeras entrenadas midieron tres veces la
presión arterial en el domicilio de los sujetos de estudio. Se
diagnosticó hipertensión arterial si la presión sistólica era
igual o mayor a 160 mm Hg y/o si la presión diastólica era
igual o mayor a 90 mm Hg o por auto reporte de un diag-
nóstico médico. Se colectó también información demográfica
y sobre factores de riesgo. Resultados. Un total de 4 777
sujetos fueron estudiados y 2 036 (43%) reconocieron un
diagnóstico previo de hipertensión; de esos, 1 954 (96/) se
encontraban bajo tratamiento farmacológico y 273 (5.7%)
fueron hallazgo del tamizaje. El 68.5% (n= 1 399) de aquellos
que recibían tratamiento y 59 (72%) de los que reportados
como hipertensos no recibían tratamiento, tuvieron una
presión arterial de menos de 160/90 mm Hg. De aquellos
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Abstract
Objective. To assess the prevalence and treatment of high
blood pressure among elderly people in Mexico. Material
and Methods. A cross-sectional study was conducted from
February to July 1998 among the elderly people covered by
the Instituto Mexicano del Seguro Social (IMSS) healthcare
services in Mexico City. The study population consisted of
4 777 subjects aged 60 years and over, selected from a co-
hort of 5 433 people, representative of the population of
Mexico City. Trained nurses carried out three blood pres-
sure measurements at home. Diagnosis of high blood
pressure was established if systolic pressure was equal to
or higher than 160 mmHg, and/or diastolic pressure was
equal or higher than 90 mmHg, or by self-report of a me-
dical diagnosis of hypertension. Demographic and risk fac-
tor information was also collected. Results. A total of 4
777 subjects were screened; 2 036 (43%) of them reported
that they had been previously diagnosed as hypertensive.
Of these, 1 954 (96%) were already on pharmacological treat-
ment. A further 273 (5.7%) subjects were found to be hy-
pertensive at screening. Among those receiving treatment,
1 399 (68.5%) had a blood pressure reading of less than
160/90 mmHg, and this was also the case for 59 (72%) of
The prevalence and treatment of hypertension
in the elderly population of the
Mexican Institute of Social Security
Carmen García-Peña, M.D., Ms.C., Ph.D.,(1) Margaret Thorogood, Ms.C., Ph.D.,(2) Sandra Reyes, M.D., Ms.C., Ph.D.,(3)
Jorge Salmerón-Castro, M.D., Ms.C., Ph.D.,(4) Carlos Durán, M.D., Ms.C.(1)
This study was funded by the National Council of Science and Technology (Conacyt) and the Mexican Institute of Social Security (IMSS).
(1) Health Services Research Area. Research Coordination. Mexican Institute of Social Security, Mexico City, Mexico.
(2) Health Promotion Research Unit. London School of Hygiene and Tropical Medicine, London, United Kingdom.
(3) Medical Research Unit on Ageing, Delegación Querétaro. Mexican Institute of Social Security, Queretaro, Mexico.
(4) Epidemiological and Health Services Research Unit. Mexican Institute of Social Security, Mexico City, Mexico.
Received on: September 20, 2000 • Accepted: November 6, 2000
Address reprint requests to: Dra. Ma. del Carmen García-Peña. División de Investigación Epidemiológica y en Servicios de Salud, Edificio Bloque “B”,
Cuarto piso, Unidad de Congresos, Centro Médico Nacional Siglo XXI. Avenida Cuauhtémoc 330, colonia Doctores, 06125 México D.F., México.
E-mail: mcgp1@terra.com.mx
ARTÍCULO ORIGINAL
416 salud pública de méxico / vol.43, no.5, septiembre-octubre de 2001
García-Peña C y col.
T he increasing proportion of the population that isaged 60 years or more and the accompanying
growing prevalence of non-communicable diseases
are important health issues in Mexico.1 The Mexican
Institute of Social Security, the most important health-
care provider in Mexico, offers medical care to a large
proportion of people aged 60 years or more.2 Morta-
lity and morbidity from non-communicable disease
have increased substantially in Mexico between 1922
and 1995.3 In that period, the percentage of all deaths
attributed to non-communicable diseases increased
from 11.8% to 55%. The incidence of hypertensive
disease has increased in Mexico by 40%, while in
the United Kingdom it fell by 24% during the period
1986-1995.4,5
Research has established the important role of high
blood pressure and its associated cardiovascular con-
ditions, in the morbidity, mortality, and disability
rates of the elderly population. High blood pressure
in the elderly has a high impact on the economy and
on the quality of life of individuals; it also has im-
portant implications for institutional resource ex-
penditures.6-8 Consideration of effective interventions
requires the assessment of the magnitude and extent
of the burden of hypertensive disease in the elderly.
To this end, this study was conducted to describe the
prevalence of hypertension among the elderly IMSS
population in Mexico City.
Material and Methods
The study population was a random sample of 5 433
subjects aged 60 years and over, representing the IMSS
population of Mexico City. Study subjects were origi-
nally selected for a study of health needs, health ser-
vices utilization, and cost of health services.2 This
cohort was selected by multistage random sampling,
first by Family Medicine Center (12 Centers selected
out of 43), and then by age-stratified sampling within
the population served by each Family Medicine Cent-
er (approximately 450 participants from each center,
selected from the assigned population). Specific sam-
ple fractions by age were used to guarantee selection
of enough subjects in each age group. Screening for
high blood pressure began one year after the cohort
was assembled, and took place from February to July
1998.
Fifteen trained nurses obtained blood pressure
readings, after obtaining informed consent and check-
ing that it was an appropriate time to measure blood
pressure. Nurses did not measure the blood pressure
if the subject had taken anti-hypertensive drugs in the
last 2 hours or had exercised, drunk coffee, or smoked
in the last hour.9 In such cases, fieldwork personnel
made another appointment.
Data on socio-demographic variables were collect-
ed by direct interviews using a structured question-
naire. Self-reported data were collected on medical
history of diabetes, angina pectoris, acute myocardial
infarction, renal failure, and hypercholesterolemia,
as well as on self-reported smoking and physical ac-
tivity.
Blood pressure was measured with a Takeda
mercurial sphygmomanometer. Special cuffs for
thicker arms were used whenever appropriate and the
equipment was calibrated regularly. The nurses
checked daily that the mercury column was at zero
millimeters before readings. Three blood pressure
measurements were taken, two when the participant
was seated and once after standing for at least two
minutes. Each of these measurements was separated
by five minutes of relaxing. Systolic blood pressure
was set at the first Korotkoff sound, while diastolic
blood pressure was read when the sound disappeared
the known hypertensives not on treatment. A single drug
was used by 1 556 (79.6%) of those on treatment. Risk
factors for hypertension were more frequent in the hy-
pertensive group (p£0.05). Conclusions. Almost half of
the elderly population is hypertensive, most of them are
already on treatment, but about one third of those on treat-
ment do not have an adequate control of high blood pres-
sure. The English version of this paper is available too at:
http://www.insp.mx/salud/index.html
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en tratamiento, 1 556 (79.6%) tomaban un solo medica-
mento. La frecuencia de factores de riesgo fue más alta en
el grupo de hipertensos (p≤0.05). Conclusiones. Casi la
mitad de la población anciana estudiada es hipertensa, mucha
de ella en tratamiento; sin embargo, una tercera parte de
éstos no tienen un adecuado control de la presión arterial.
El texto completo en inglés de este artículo está también
disponible en: http://www.insp.mx/salud/index.html
Palabras clave: hipertensión; prevalencia; anciano; enferme-
dades crónicas; México
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completely (phase V of Korotkoff sounds). The cuff-
deflation rate was 2 mm/second and the reading
made to the nearest 2 mm Hg.9,10 Nurses recorded all
the measurements and the mean of the two seated
blood pressure readings was calculated using a com-
puter. The standing blood pressure figures were used
to detect hypotension. At the end of the visit, the nurse
gave participants a written result of the blood pres-
sure readings and advised them to visit their family
physicians.
Hypertension was diagnosed when either the
mean seated systolic blood pressure was equal to or
higher than 160 mm Hg, or the mean diastolic blood
pressure was equal to or higher than 90 mm Hg, or
both.
Standing blood pressure was used to diagnose
hypotension. Nurses applied the Osler’s manoeuvre11
in all the participants with blood pressure readings
above 160/90 mm Hg. Those found to have a positive
Osler’s manoeuvre were not defined as hypertensive.
Subjects with a previous diagnosis of hypertension or
high blood pressure made by a medical doctor were
defined as hypertensive. Treatment of hypertension
was defined as self-reported current use of a prescribed
medication affecting blood pressure. Participants who
had a personal history of hypertension but who report-
ed that they were not currently taking antihyperten-
sive drugs were defined as hypertensive.
Data were entered in electronic format using an
optical reader and analyzed using SPSS version 6.0.
Statistical analysis consisted of descriptive statistics
and difference of proportions. The analysis was car-
ried out in two ways: first assuming an unweighted
sample and then with the sample weighted by age
group sample fractions.
The proposal was approved by the Research
Committee of the Mexican Institute of Social Security
Research Coordination and by the Ethics Committee
of the London School of Hygiene and Tropical Medi-
cine.
Results
Two hundred and sixteen (3.9%) participants had died
before the hypertension prevalence study began. Fif-
ty-four people (0.9%) refused to participate in the study
and 386 people (7.1%) could not be found. Thus, the
total non-response rate from the original sample was
12.1%, leaving 4 777 participants who were screened.
Of these, a total of 2 036 (43%) reported that a doctor
had diagnosed them as hypertensive and 1 954 (96%)
were on antihypertensive therapy. A further 273 (5.7%)
subjects were found to be hypertensive at screening,
as defined in the previous section. Distributions of
prevalence by gender, adjusted by age, are present-
ed in Table I. The prevalence is higher in females, ex-
cept in the group of newly-diagnosed patients. One
hundred and twenty nine participants had a positive
Osler manoeuvre, and therefore were excluded from
the hypertensive group because of possible pseudo-
hypertension. In total, 2 309 participants (48.3%) were
diagnosed as hypertensive. This proportion did not
change when the analysis was carried out as a weight-
ed sample.
Table II shows selected demographic, lifestyle,
and clinical variables, by the presence or absence of
Table I
PREVALENCE OF HYPERTENSION BY GENDER, ADJUSTED BY AGE GROUP. MEXICO CITY, MEXICO, 1998
60-64 65-69 70-74 75-79 80 and more Total*
F‡ M‡ F M F M F M F M F M
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Known hypertensives
on treatment 312 (41.9) 123 (31.8) 402 (44.9) 197 (33.3) 275 (45.3) 159.4 (37.5) 171.6 (52.9) 111 (36.5) 136 (46.6) 68 (32.5) 1296 (45.3) 658 (34.3)
Known hypertensives
not treated 16 (2.2) 2 (0.5) 16 (1.8) 13.9 (2.3) 17.3 (2.8) 4 (0.9) 7 (2.2) 5 (1.6) 0.3 (0.1) 0.1 (0.04) 57 (1.2) 25 (1.3)
Newly diagnosed 27.9 (3.8) 33 (8.5) 39 (4.4) 37 (6.3) 34 (5.6) 34 (8.0) 15 (4.6) 23 (7.6) 18 (6.2) 13 (6.2) 133 (4.6) 140 (7.3)
Subtotal 359 (48.3) 160 (41.5) 457 (51.1) 246 (41.5) 324 (53.4) 196 (46.1) 191 (58.9) 139 (45.7) 155 (53.1) 82 (39.2) 1 486 (51.9) 823 (42.9)
Normotensive 386.3 (51.9) 226 (58.5) 438 (48.9) 346 (58.5) 283 (46.6) 227.5 (53.5) 130.3 (40.2) 163.9 (53.9) 137 (46.9) 128.2 (60.) 1 375 (48.1) 1 093 (57.1)
Total 743 386 895 592 607 425 324 304 292 209 2 861 1 916
* Total not adjusted
‡ F= female, M=male
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hypertension. There was no significant difference in
the mean age or educational level between the groups.
More women than men were hypertensive, and this
group also had fewer married and more widowed sub-
jects, probably due to the greater number of females.
The non-hypertensive group included significantly
more smokers (19.1% vs. 11.4%) (≤£0.01), while the hy-
pertensive group reported significantly more co-mor-
bidity. The hypertensive group was further divided
into three sub-groups: newly-diagnosed participants
(n=273), previously known hypertensives on treatment
(n=1 954), and previously known hypertensives not
on treatment (n=82). Of those known hypertensives on
treatment, 1 399 (68.5%) had a blood pressure reading
of less than 160/90 mm Hg, and this was also the case
for 59 (72%) of the known hypertensives not on treat-
ment (Table III). An isolated elevated diastolic blood
pressure reading (≥90 mm Hg) was found in 157 par-
ticipants (57.5%) in the new diagnosis group, but in
less than 15% of the known hypertensives with or with-
out treatment. Isolated systolic hypertension (≥160 mm
Hg) was less frequent; 24.5% in the new diagnosis
group, 8.4% in the known hypertensives on treatment,
and 7.3% in the group without treatment (Table III). A
total of 16.5% of those with seating blood pressure
readings higher than 160/90 mm Hg had standing hy-
potension.
Among those participants receiving antihy-
pertensive treatment, 1 556 (79.6%) were taking a sin-
gle drug and only 38 (1.9%) were taking three or more
drugs (Table IV). The most common single treatment
was an angiotensin-converting enzyme (ACE) inhibi-
tor (53.9%). Among those receiving two drugs, a com-
mon combination was a diuretic with an ACE inhibitor
(13.3%) (Table IV).
Discussion
Hypertension is common among elderly people and is
accompanied by a high risk of cardiovascular disease.
This paper reports the first study of hypertension in
elderly people in Mexico, and describes the preva-
lence of, and treatment for hypertension, in a repre-
sentative sample. Other studies in Mexico have found
a prevalence of hypertension between 4.7% and 29.2%
Table II
GENERAL CHARACTERISTICS IN HYPERTENSIVE
AND NORMOTENSIVE SUBJECTS.
MEXICO CITY, MEXICO, 1998
Variables Non hypertensives All Hypertensives*
n=2 468 n=2 309
% %
Age
Mean age in years (SD) 69.9 (7.1) 70.3 (6.9)
Gender
Female 55.7 64.4
Highest education level
Primary 56.5 57.1
Secondary/Technical 13.6 13.2
High school 2.3 2.0
College/more 5.2 4.7
None 22.2 22.8
Missing 0.4 0.6
Marital status
Married 64.7 60.7
Single 4.4 3.8
Divorced 3.5 3.6
Widowed 26.9 30.6
Missing 0.4 0.6
Lifestyle risk factors
No physical activity 77.4 79.4
Current smoking 19.1 11.4‡
Clinical risk factors
Diabetes 20.7 25.8‡
Angor pectoris 1.0 2.6‡
Acute myocardial infarction 3.0 5.4‡
Renal failure 1.0 1.6
Hypercholesterolemia 8.0 13.0*
* Known hypertensives + diagnosed through screening
‡ p value ≤0.0005 Table III
BLOOD PRESSURE READINGS IN THE HYPERTENSIVE
GROUP BY DIAGNOSIS AND TREATMENT.
MEXICO CITY, MEXICO, 1998
Blood pressure New Known Known Total
diagnosis hypertensives hypertensives hypertensives
on treatment not treated
n=273 % n=1954 % n=82 % n=2309 %
<160/90 – 1 339 68.5  59 72.0 1 398  60.6
Diastolic ≥90 157 57.5 283 14.5  11 13.4  451 19.5
Systolic ≥160  67 24.5 165 8.4   6 7.3  238 10.3
≥90 + ≥160  49 17.9 167 8.5   6 7.3  222  9.6
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of the overall adult population.12-14 However, none of
these studies has focused on people aged over 60
years. In the United States, the National High Blood
Pressure Education Program Working Group15
found a prevalence of hypertension (defined as systo-
lic blood pressure above 140 mm Hg and/or diastolic
blood pressure above 90 mm Hg) of approximately 40%
in a subgroup of people aged 65 years or more.
We found that almost half (48%) of the elderly
population is hypertensive (defined as a systolic equal
to or above 160 mm Hg and/or a diastolic equal to or
above 90 mm Hg or as self-reported hypertension).
Of those people who were previously known as hy-
pertensive, 39% did not have adequate control of their
blood pressure, that is, they had levels of blood pres-
sure equal to or higher than 160/90 mm Hg. This fig-
ure is similar to that found for the age group of 60 to
69 years old in the National Survey of Chronic Dis-
ease.3 Lerman et al16 reported a prevalence of hyper-
tension (defined as a systolic above 160 mm Hg and a
diastolic equal to 90 mm Hg) of almost 50% in both
males and females in the group aged 60 years and more.
Even with the limitations imposed by the sample size
of the study, they found similar data.
One of the strengths of this study was the accu-
rate measurement of blood pressure. External factors
and factors related to the measurement technique,
such as posture, cuff size, and equipment were care-
fully controlled.10 While there was a risk of overesti-
mating the proportion of new hypertensives by using
measurements taken on a single occasion, this risk was
decreased because the blood pressure measurements
were made at home. Almost all trials of pharmacolog-
ical treatment17-20 have made repeated measurements,
but none of them have measured the blood pressure in
the patient’s home. Stergiou et al21 studied 189 hyper-
tensive patients and found that the mean blood pres-
sure measured at home was lower than the mean clinic
blood pressure by 5.1 mm Hg on average, in both systo-
lic and diastolic blood pressure readings(p<0.001).
A high percentage (96%) of those known to be
hypertensive were receiving pharmacological treat-
ment, although nearly a third of those on treatment
(32 %) had blood pressure levels equal to or higher
than 160/90 mm Hg, and a further significant pro-
portion had levels higher than 140/90 mm Hg. A small
number (n=59) of participants had been diagnosed as
hypertensive, but were not on treatment and had blood
pressure values below 160/90 mmHg; this group may
have been incorrectly diagnosed.
Nearly 6% of the people screened were unaware
of being hypertensive before screening. This propor-
tion of new hypertensives is small in comparison
with that reported in other studies. In the 1994 Health
Survey for England, 38% of people aged 65 years and
older had a previously unknown diagnosis of hyper-
tension.22 In the National Survey of Chronic Diseases,3
25% of people aged 60 to 69 years had a previously
unknown diagnosis of hypertension. The reason for the
difference between the National Survey and this study
may be that the population included in this study is
covered by the Social Security healthcare system and
regularly attends family medicine units. The average
number of consultations at IMSS is 2.9 per year in this
group of age, higher than that for the population at
large,2 therefore, the former group had a greater chance
to be diagnosed.
Overall, physicians prescribed more expensive
hypertensive drugs (ACE inhibitors, beta-blockers, and
calcium antagonists), rather than the first election drug,
diuretics, which were prescribed to only 2% of pa-
tients. In those being prescribed two drugs, one of the
least frequent combinations was a diuretic with a
beta-blocker (9%). The excessive prescription of cap-
topril, for instance, imposes a high financial burden
on healthcare services. Although patients do not pay
directly for the drugs, it is important that family phy-
sicians realize that diuretics are both cheaper and clin-
ically better for the patient. The quality of care provided
by family physicians to elderly people should be an
area of future research.
Table IV
NUMBER AND TYPES OF DRUGS USED IN THOSE WITH
KNOWN HYPERTENSION. MEXICO CITY, MEXICO, 1998
Number of drugs N=1954 %
One 1 556 79.6
ACE inhibitors 839 53.9
Beta blockers 270 17.4
Calcium antagonist 308 19.9
Diuretics 35 2.2
Others 104 6.6
Two 360 18.4
Diuretic+ACE inhibitors 48 13.3
Diureutic+Beta blockers 32 8.8
Diuretic+Calcium antagonists 32 8.8
Others 112 69.1
Three 35 1.8
Four 3 0.15
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We were surprised to find a number of highly
qualified nurses who were not using the correct tech-
nique to measure blood pressure when they were first
observed. Future programs for hypertension control
in Mexico must begin with careful training in the tech-
niques of measurement.
The implications of the high percentage of hyper-
tensive people in the elderly population are important
at two levels. At the individual level it is important to
consider the impact on quality of life, the complica-
tions and drug therapy, and the economic burden of
the disease. At the institutional level, the expected in-
crease in utilization rates of those with hypertension,
stroke, and other cardiovascular diseases will put a
considerable strain on the system at the primary, sec-
ondary, and tertiary levels of care.
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